Document is current
Any future updates will be listed below
-
Authors
Miettinen, Teemu P
Peltier, Julien
Härtlova, Anetta
Gierliński, Marek
Jansen, Valerie M
Trost, Matthias https://orcid.org/0000-0002-5732-700X
Björklund, Mikael
-
Funding
Funding for this research was provided by:
Division of Signal Transduction Therapy
AstraZeneca
Boehringer‐Ingelheim
GlaxoSmithKline
Janssen Pharmaceuticals
Merck KGaA
Pfizer
Wellcome (097945/Z/11/Z)
Wellcome (110275/Z/15/Z)
RCUK | Medical Research Council (MC_UU_12016/5)
RCUK | Biotechnology and Biological Sciences Research Council (BB/L008874/1)
Conquer Cancer Foundation (8364)
Susan G. Komen (15329319)
Vanderbilt University School of Medicine (2K12CA090625‐17)
- License Information
-
More Information
Article History
Received: 9 October 2017
Revised: 2 March 2018
Accepted: 9 March 2018
First Online: 18 April 2018
Conflict of interest
: The authors declare that they have no conflict of interest.
